Your browser doesn't support javascript.
loading
ATF6α regulates morphological changes associated with senescence in human fibroblasts.
Druelle, Clémentine; Drullion, Claire; Deslé, Julie; Martin, Nathalie; Saas, Laure; Cormenier, Johanna; Malaquin, Nicolas; Huot, Ludovic; Slomianny, Christian; Bouali, Fatima; Vercamer, Chantal; Hot, David; Pourtier, Albin; Chevet, Eric; Abbadie, Corinne; Pluquet, Olivier.
Afiliación
  • Druelle C; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Drullion C; Department of Anatomy and Neuroscience, Biosciences Institute, University College Cork, Cork, Ireland.
  • Deslé J; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Martin N; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Saas L; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Cormenier J; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Malaquin N; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Huot L; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Slomianny C; Institut du Cancer de Montréal, Montréal, QC, Canada.
  • Bouali F; Université de Lille, Institut Pasteur de Lille, INSERM, CNRS UMR8204, Centre d'Infection et d'Immunité de Lille, Lille, France.
  • Vercamer C; Université de Lille, INSERM U1003, Villeneuve d'Ascq, France.
  • Hot D; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Pourtier A; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Chevet E; Université de Lille, Institut Pasteur de Lille, INSERM, CNRS UMR8204, Centre d'Infection et d'Immunité de Lille, Lille, France.
  • Abbadie C; Université de Lille, Institut Pasteur de Lille, CNRS UMR8161, Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France.
  • Pluquet O; Oncogenesis, Stress, Signaling, INSERM ER-440 Université de Rennes, Rennes, France.
Oncotarget ; 7(42): 67699-67715, 2016 Oct 18.
Article en En | MEDLINE | ID: mdl-27563820
ABSTRACT
Cellular senescence is known as an anti-tumor barrier and is characterized by a number of determinants including cell cycle arrest, senescence associated ß-galactosidase activity and secretion of pro-inflammatory mediators. Senescent cells are also subjected to enlargement, cytoskeleton-mediated shape changes and organelle alterations. However, the underlying molecular mechanisms responsible for these last changes remain still uncharacterized. Herein, we have identified the Unfolded Protein Response (UPR) as a player controlling some morphological aspects of the senescent phenotype. We show that senescent fibroblasts exhibit ER expansion and mild UPR activation, but conserve an ER stress adaptive capacity similar to that of exponentially growing cells. By genetically invalidating the three UPR sensors in senescent fibroblasts, we demonstrated that ATF6α signaling dictates senescence-associated cell shape modifications. We also show that ER expansion and increased secretion of the pro-inflammatory mediator IL6 were partly reversed by silencing ATF6α in senescent cells. Moreover, ATF6α drives the increase of senescence associated-ß-galactosidase activity. Collectively, these findings unveil a novel and central role for ATF6α in the establishment of morphological features of senescence in normal human primary fibroblasts.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Senescencia Celular / Factor de Transcripción Activador 6 / Respuesta de Proteína Desplegada / Fibroblastos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Child / Female / Humans / Infant / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Senescencia Celular / Factor de Transcripción Activador 6 / Respuesta de Proteína Desplegada / Fibroblastos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Child / Female / Humans / Infant / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Francia